133 related articles for article (PubMed ID: 23797236)
1. Adult acute lymphoblastic leukemia: a cancer with no standard of care.
Douer D
Acta Haematol; 2013; 130(3):196-8. PubMed ID: 23797236
[No Abstract] [Full Text] [Related]
2. [Treatment strategy for adult acute lymphoblastic leukemia].
Okamoto S
Rinsho Ketsueki; 2002 Jun; 43(6):427-32. PubMed ID: 12134694
[No Abstract] [Full Text] [Related]
3. [Acute lymphoblastic leukemia and chronic lymphocytic leukemia in adults].
Usui N
Rinsho Ketsueki; 2012 Feb; 53(2):164-75. PubMed ID: 22450575
[No Abstract] [Full Text] [Related]
4. Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands.
de Bont JM; Holt Bv; Dekker AW; van der Does-van den Berg A; Sonneveld P; Pieters R
Leukemia; 2004 Dec; 18(12):2032-5. PubMed ID: 15483674
[No Abstract] [Full Text] [Related]
5. [Peripheral blood stem cell transplantation in adult acute lymphoblastic leukemia as postremission therapy].
Kuribara R; Muroi K; Yoshida M; Suzuki T; Izumi T; Hatake K; Amemiya Y; Miura Y
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1613-7. PubMed ID: 9725058
[No Abstract] [Full Text] [Related]
6. [Treatment strategy for childhood and adolescent acute lymphoblastic leukemia in first remission].
Hori H
Rinsho Ketsueki; 2010 Jul; 51(7):454-9. PubMed ID: 20693762
[No Abstract] [Full Text] [Related]
7. [Treatment strategy for the patients with Philadelphia chromosome negative acute lymphoblastic leukemia in first remission].
Takeuchi J
Rinsho Ketsueki; 2010 Jul; 51(7):460-3. PubMed ID: 20693763
[No Abstract] [Full Text] [Related]
8. [Management of acute lymphoblastic leukemia].
Usui N
Rinsho Ketsueki; 2008 Oct; 49(10):1374-85. PubMed ID: 18833922
[No Abstract] [Full Text] [Related]
9. Acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group (ALL-REZ BFM) experience: early treatment intensity makes the difference.
Herold R; von Stackelberg A; Hartmann R; Eisenreich B; Henze G
J Clin Oncol; 2004 Feb; 22(3):569-70; author reply 570-1. PubMed ID: 14752084
[No Abstract] [Full Text] [Related]
10. Current therapeutic strategies in adult acute lymphoblastic leukemia.
Fielding AK
Hematol Oncol Clin North Am; 2011 Dec; 25(6):1255-79, viii. PubMed ID: 22093586
[TBL] [Abstract][Full Text] [Related]
11. High-risk acute lymphoblastic leukemia (ALL): is there an alternative approach for increasing the number of cures?
Carella AM
Haematologica; 1992; 77(4):348-51. PubMed ID: 1358772
[No Abstract] [Full Text] [Related]
12. Imatinib interim therapy between chemotherapeutic cycles and in vivo purging prior to autologous stem cell transplantation, followed by maintenance therapy is a feasible treatment strategy in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Shin HJ; Chung JS; Cho GJ
Bone Marrow Transplant; 2005 Nov; 36(10):917-8. PubMed ID: 16113662
[No Abstract] [Full Text] [Related]
13. [Autotransplantation in acute leukemia using totipotent cells mobilized with filgrastim].
Ruiz-Argüelles GJ; Ruiz-Argüelles A; Alemán-Hoey DD; Arizpe Bravo D; Martin-López A; Ocejo Rodríguez A
Rev Invest Clin; 1993; 45(5):479-80. PubMed ID: 7510900
[No Abstract] [Full Text] [Related]
14. [Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].
Qin Y; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang JL; Yang S; Zhang CG; Dong M; Zhou LQ; Wang JW; Feng FY; Sun Y
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):469-73. PubMed ID: 19950562
[TBL] [Abstract][Full Text] [Related]
15. Recurrent aleukemic leukemia cutis in a patient with pre-B-cell acute lymphoblastic leukemia.
Ansell LH; Mehta J; Cotliar J
J Clin Oncol; 2013 Jul; 31(20):e353-5. PubMed ID: 23733764
[No Abstract] [Full Text] [Related]
16. [Imatinib combined with modified hyper-CVAD/MA followed by allogeneic hematopoietic stem cell transplantation in CR1 as the front-line therapy for adult Ph(+) acute lymphoblastic leukemia].
Huang J; Zou DH; Fu MW; Li ZJ; Xu Y; Zhao YZ; Qi JY; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):673-8. PubMed ID: 22339825
[TBL] [Abstract][Full Text] [Related]
17. Rituximab can be useful as treatment for minimal residual disease in bcr-abl-positive acute lymphoblastic leukemia.
Jándula BM; Nomdedeu J; Marín P; Vivancos P
Bone Marrow Transplant; 2001 Jan; 27(2):225-7. PubMed ID: 11281397
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.
Azuma T; Tobinai K; Takeyama K; Shibata T; Hidaka M; Kurosawa M; Kasai M; Chou T; Fukushima N; Mukai K; Tsukasaki K; Shimoyama M;
Jpn J Clin Oncol; 2012 May; 42(5):394-404. PubMed ID: 22422899
[TBL] [Abstract][Full Text] [Related]
19. The role of peripheral blood stem cells as rescue after myeloablative therapy.
Reiffers J; Marit G; Boiron JM; Rice A; Bernard P; Vezon G
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():212-4. PubMed ID: 2565746
[No Abstract] [Full Text] [Related]
20. [Risk-adapted therapeutic stratification of infantile acute lymphocytic leukemia based on MLL-gene rearrangement].
Tomizawa D
Rinsho Ketsueki; 2008 Mar; 49(3):171-81. PubMed ID: 18421958
[No Abstract] [Full Text] [Related]
[Next] [New Search]